Metabolic syndrome among individuals with heroin use disorders on methadone therapy: Prevalence, characteristics, and related factors

References

• United Nations Office on Drugs and Crime (UNODC). World Drug Report 2016. https://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf. Accessed April 15, 2017.
   Google Scholar
• Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. 2015;9:358–367.
   PubMed Web of Science ®Google Scholar
• Chou R, Cruciani RA, Fiellin DA, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on problems of drug dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15:321–337.
   PubMed Web of Science ®Google Scholar
• Cooper OB, Brown TT, Dobs AS. Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis. 2003;37:132–136.
   PubMed Web of Science ®Google Scholar
• Reed JL, Ghodse AH. Oral glucose tolerance and hormonal response in heroin-dependent males. BMJ. 1973;2:582–585.
   PubMed Web of Science ®Google Scholar
• Willenbring ML, Morely JE, Krahn DD, Carlson GA, Levine AS, Shafer RB. Psychoneuroendocrine effects of methadone maintenance. Psychoneuroendocrinology. 1989;14:371–337.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Giugliano D, Passariello N, et al. Impaired glucose metabolism in heroin and methadone users. Horm Metab Res. 1987;19:430–433.
   PubMed Web of Science ®Google Scholar
• Passariello N, Giugliano D, Quatraro A, et al. Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism. 1983;32:1163–1165.
   PubMed Web of Science ®Google Scholar
• Passariello N, Giugliano D, Ceriello A, Chiariello A, Sgambato S, D'Onofrio F. Impaired insulin response to glucose but not to arginine in heroin addicts. J Endocrinol Invest. 1986;9:353–357.
   PubMed Web of Science ®Google Scholar
• Pereska Z, Bozinovska C, Dimitrovski C, et al. Heroin dependence duration influences the metabolic parameters: mechanisms and consequences of impaired insulin sensitivity in hepatitis C virus seronegative heroin dependents. J Addict Med. 2012;6:304–310.
   PubMed Web of Science ®Google Scholar
• Fareed A, Byrd-Sellers J, Vayalapalli S, Drexler K, Phillips L. Predictors of diabetes mellitus and abnormal blood glucose in patients receiving opioid maintenance treatment. Am J Addict. 2013;22:411–416.
   PubMed Web of Science ®Google Scholar
• Howard AA, Floris-Moore M, Lo Y, Arnsten JH, Fleischer N, Klein RS. Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med. 2006;7:389–396.
   PubMed Web of Science ®Google Scholar
• Howard AA, Floris-Moore M, Arnsten JH, et al. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis. 2005;40:1492–1499.
   PubMed Web of Science ®Google Scholar
• Fareed A, Musselman D, Byrd-Sellers J, et al. On-site basic health screening and brief health counseling of chronic medical conditions for veterans in methadone maintenance treatment. J Addict Med. 2010;4:160–166.
   PubMed Web of Science ®Google Scholar
• Maruyama A, Macdonald S, Borycki E, Zhao J. Hypertension, chronic obstructive pulmonary disease, diabetes and depression among older methadone maintenance patients in British Columbia. Drug Alcohol Rev. 2013;32:412–418.
   PubMed Web of Science ®Google Scholar
• Mysels DJ, Sullivan MA. The relationship between opioid and sugar intake: review of evidence and clinical applications. J Opioid Manag. 2010;6:445–452.
   PubMedGoogle Scholar
• Yousefzadeh G, Shokoohi M, Najafipour H, Eslami M, Salehi F. Association between opium use and metabolic syndrome among an urban population in Southern Iran: results of the Kerman Coronary Artery Disease Risk Factor Study (KERCADRS). ARYA Atheroscler. 2015;11:14–20.
   PubMed Web of Science ®Google Scholar
• Mattoo SK, Nebhinani N, Aggarwal M, Basu D, Kulhara P. Metabolic syndrome among substance dependent men: a study from north India. Ind Psychiatry J. 2013;22:60–64.
   PubMedGoogle Scholar
• Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther. 2007;82:509–524.
   PubMed Web of Science ®Google Scholar
• Prasad H, Ryan DA, Celzo MF, Stapleton D. Metabolic syndrome: definition and therapeutic implications. Postgrad Med. 2012;124:21–30.
   PubMed Web of Science ®Google Scholar
• Vallecillo G, Mojal S, Roquer A, et al. Low non-structured antiretroviral therapy interruptions in HIV-infected persons who inject drugs receiving multidisciplinary comprehensive HIV care at an outpatient drug abuse treatment center. AIDS Behav. 2015;20:1068–1075.
   Web of Science ®Google Scholar
• Domecq JP, Prutsky G, Leppin A, et al. Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:363–370.
   PubMed Web of Science ®Google Scholar
• ISAK (International Standards for Anthropometric Assessment). International Standards for Anthropometric Assessment. Lower Hutt, New Zealand: ISAK; 2011. http://www.ceap.br/material/MAT17032011184632.pdf. Accessed April 15, 2017..
   Google Scholar
• World Health Organization Consultation on Obesity. Obesity: Preventing And Managing the Global Epidemic. Report of a WHO consultation. Geneva, Switzerland: World Health Organization; 2000.
   Google Scholar
• Grundy SM, Brewer BH Jr, Cleeman JI, Smith SC Jr, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438.
   PubMed Web of Science ®Google Scholar
• Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121:21–33.
   PubMed Web of Science ®Google Scholar
• Tauler P, Bennasar-Veny M, Morales-Asencio JM, et al. Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATP III diagnostic criteria: relationship with cardiovascular risk factors. PLoS ONE. 2014;9:e89281.
   PubMed Web of Science ®Google Scholar
• Seow LS, Chong SA, Wang P, Shafie S, Ong HL, Subramaniam M. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care. Compr Psychiatry. 2017;74:196–203.
   PubMed Web of Science ®Google Scholar
• Scuteri A, Laurent S, Cucca F, et al. Metabolic syndrome across Europe: different clusters of risk factors. Eur J Prev Cardiol. 2015;22:486–491.
   PubMed Web of Science ®Google Scholar
• Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J Am Coll Cardiol. 2013;62:697–703.
   PubMed Web of Science ®Google Scholar
• Marcuello C, Calle-Pascual AL, Fuentes M, et al. Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the [email protected] study. Acta Diabetol. 2013;50:615–623.
   PubMed Web of Science ®Google Scholar
• Fenn JM, Laurent JS, Sigmon SC. Increases in body mass index following initiation of methadone treatment. J Subst Abuse Treat. 2015;51:59–63.
   PubMed Web of Science ®Google Scholar
• Peles E, Schreiber S, Sason A, Adelson M. Risk factors for weight gain during methadone maintenance treatment. Subst Abus. 2016;37:613–618.
   PubMed Web of Science ®Google Scholar
• Mysels DJ, Vosburg SK, Benga I, Levin FR, Sullivan MA. Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients. J Opioid Manag. 2011;7:47–53.
   PubMedGoogle Scholar
• Nolan LJ, Scagnelli LM. Preference for sweet foods and higher body mass index in patients being treated in long-term methadone maintenance. Subst Use Misuse. 2007;42:1555–1566.
   PubMed Web of Science ®Google Scholar
• McElroy SL. Obesity in patients with severe mental illness: overview and management. J Clin Psychiatry. 2009;70:12–21.
   PubMed Web of Science ®Google Scholar
• Manu P, Dima L, Shulman M, Vancampfort D, De Hert M Correll CU. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr Scand. 2015;132:97–108.
   PubMed Web of Science ®Google Scholar
• Nihalani N, Schwartz TL, Siddiqui UA, Megna JL. Weight gain, obesity, and psychotropic prescribing. J Obes. 2011;2011:893629.
   PubMedGoogle Scholar
• Ersche KD, Stochl J, Woodward JM, Fletcher PC. The skinny on cocaine: insights into eating behavior and body weight in cocaine-dependent men. Appetite. 2013;71:75–80.
   PubMed Web of Science ®Google Scholar
• Suter PM. Is alcohol consumption a risk factor for weight gain and obesity? Crit Rev Clin Lab Sci. 2005;42:197–227.
   PubMed Web of Science ®Google Scholar
• Sansone RA, Sansone LA. Marijuana and body weight. Innov Clin Neurosci. 2014;11:50–54.
   PubMedGoogle Scholar
• Banks DE, Bogler Y, Bhuket T, Liu B, Wong RJ. Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S. Diabetes Metab Syndr. [published online December 13, 2016]. doi: 10.1016/j.dsx.2016.12.025.
   PubMed Web of Science ®Google Scholar
• Han B, Gfroerer JC, Colliver JD, Penne MA. Substance use disorder among older adults in the United States in 2020. Addiction. 2009;104:88–96.
   PubMed Web of Science ®Google Scholar